VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
FIGHT-302: A New Chapter in First-Line Targeted Therapy for FGFR2-Rearranged Cholangiocarcinoma
FIGHT-302: A New Chapter in First-Line Targeted Therapy for FGFR2-Rearranged Cholangiocarcinoma
May 22, 2026 19:35 CST Updated May 23, 02:36
Share:
